What is the price target for ACM stock?
18 analysts have analysed ACM and the average price target is 128.76 USD. This implies a price increase of 49.92% is expected in the next year compared to the current price of 85.89.
NYSE:ACM • US00766T1007
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for AECOM (ACM).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-02-11 | RBC Capital | Maintains | Outperform -> Outperform |
| 2026-02-11 | Barclays | Maintains | Equal-Weight -> Equal-Weight |
| 2026-02-11 | Truist Securities | Reiterate | Buy -> Buy |
| 2026-02-10 | UBS | Maintains | Buy -> Buy |
| 2026-02-10 | B of A Securities | Maintains | Buy -> Buy |
| 2026-01-28 | Goldman Sachs | Maintains | Buy -> Buy |
| 2026-01-26 | Citigroup | Maintains | Buy -> Buy |
| 2026-01-21 | UBS | Maintains | Buy -> Buy |
| 2025-12-22 | Barclays | Downgrade | Overweight -> Equal-Weight |
| 2025-12-18 | Truist Securities | Maintains | Buy -> Buy |
| 2025-11-21 | Truist Securities | Maintains | Buy -> Buy |
| 2025-11-21 | Baird | Downgrade | Outperform -> Neutral |
| 2025-11-20 | Argus Research | Maintains | Buy -> Buy |
| 2025-11-20 | RBC Capital | Maintains | Outperform -> Outperform |
| 2025-11-20 | Barclays | Maintains | Overweight -> Overweight |
| 2025-11-19 | UBS | Maintains | Buy -> Buy |
| 2025-11-19 | Baird | Maintains | Outperform -> Outperform |
| 2025-11-19 | Citigroup | Maintains | Buy -> Buy |
| 2025-10-20 | Keybanc | Maintains | Overweight -> Overweight |
| 2025-10-20 | Barclays | Maintains | Overweight -> Overweight |
| 2025-10-20 | Citigroup | Maintains | Buy -> Buy |
| 2025-10-08 | Truist Securities | Maintains | Buy -> Buy |
| 2025-08-12 | Barclays | Maintains | Overweight -> Overweight |
| 2025-08-06 | UBS | Maintains | Buy -> Buy |
| 2025-08-06 | Keybanc | Maintains | Overweight -> Overweight |
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 14.378B 9.36% | 16.105B 12.01% | 16.14B 0.21% | 8.02B -50.31% | 8.514B 6.16% | 10.719B 25.90% | N/A | N/A | |
| EBITDA YoY % growth | 966.7M 10.87% | 1.103B 14.10% | 1.235B 11.94% | 1.313B 6.33% | 1.445B 10.05% | 1.594B 10.31% | 1.809B 13.49% | 1.877B 3.76% | |
| EBIT YoY % growth | 791M 12.84% | 924.236M 16.84% | 1.059B 14.57% | 1.197B 13.05% | 1.313B 9.69% | 1.427B 8.68% | 1.703B 19.34% | 1.761B 3.41% | |
| Operating Margin | 5.50% | 5.74% | 6.56% | 14.93% | 15.42% | 13.31% | N/A | N/A | |
| EPS YoY % growth | 3.73 7.49% | 4.52 21.18% | 5.26 16.37% | 6.00 14.08% | 6.69 11.51% | 7.57 13.14% | 9.12 20.46% | 9.71 6.42% |
All data in USD
| Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | Q1 / 28 | Q2 / 28 | Q3 / 28 | Q4 / 28 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 1.58 26.73% | 1.59 18.35% | 1.54 13.02% | 1.40 8.75% | 1.52 -4.15% | 1.75 10.60% | 1.86 21.13% | 1.55 10.15% | 1.68 10.42% | 1.92 9.40% | 1.99 6.87% |
| Revenue Q2Q % growth | 1.985B -47.37% | 2.1B -49.74% | 2.107B -49.54% | 1.963B -48.76% | 2.081B 4.84% | 2.178B 3.71% | 2.195B 4.18% | 3.167B 61.33% | 2.987B 43.54% | 3.264B 49.86% | 3.216B 46.51% |
| EBITDA Q2Q % growth | 315.79M -5.60% | 350.81M -15.91% | 348.67M -25.39% | 316.41M 8.29% | 332.13M 5.17% | 375.27M 6.97% | 379.55M 8.86% | 331.73M 4.84% | 355.15M 6.93% | 403.45M 7.51% | 414M 9.08% |
| EBIT Q2Q % growth | 287.79M 14.79% | 321.64M 11.38% | 322.88M 10.79% | 290.7M 21.05% | 306.72M 6.58% | 343.67M 6.85% | 346.36M 7.27% | 299.07M 2.88% | 321.15M 4.70% | 362.73M 5.55% | 374.07M 8.00% |
All data in USD
18 analysts have analysed ACM and the average price target is 128.76 USD. This implies a price increase of 49.92% is expected in the next year compared to the current price of 85.89.
AECOM (ACM) will report earnings on 2026-05-04.
The consensus EPS estimate for the next earnings of AECOM (ACM) is 1.58 USD and the consensus revenue estimate is 1.99B USD.
The consensus rating for AECOM (ACM) is 81.1111 / 100 . This indicates that analysts generally have a positive outlook on the stock.